Ryan Irving
About Ryan Irving
Ryan Irving is a Research Associate II at Asklepios BioPharmaceutical, Inc., with a focus on gene therapy operations and upstream cell culture processes. He has a Bachelor of Science in Biology from the University of North Carolina at Wilmington and has held various positions in the biotechnology field since 2011.
Work at Asklepios BioPharmaceutical
Ryan Irving has been employed as a Research Associate II at Asklepios BioPharmaceutical, Inc. (AskBio) since 2020. In this role, he focuses on gene therapy operations, contributing to the company's research and development efforts in the biotechnology sector. His experience in upstream cell culture is particularly relevant to the projects he undertakes at AskBio.
Previous Experience in Gene Therapy Operations
Before joining Asklepios BioPharmaceutical, Ryan Irving worked at Pfizer as a Gene Therapy Operations Specialist I from 2019 to 2020. His responsibilities included supporting gene therapy projects, which enhanced his expertise in the field. Additionally, he held positions at PPD as Project Assistant II and Project Assistant, where he gained valuable experience in project management within the biotechnology industry.
Background in Respiratory Care
Ryan Irving began his career in the medical field as a Respiratory Technician at Medical Center Respiratory from 2011 to 2012. This role provided him with foundational knowledge in patient care and respiratory health. He also worked briefly at Corning Incorporated as a Fiber Processing Associate, further diversifying his skill set in a technical environment.
Education and Expertise
Ryan Irving earned a Bachelor of Science (BS) degree in Biology from the University of North Carolina at Wilmington, completing his studies from 2008 to 2013. His academic background supports his professional expertise in gene therapy operations, particularly in scaling upstream cell culture processes from vial to 2000L single-use bioreactors.